Cargando…

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer

Evaluating the therapeutic response and survival of lung cancer patients receiving first‐line chemotherapy has always been difficult. Limited biomarkers for evaluation exist and as a result histology represents an empiric tool to guide therapeutic decision making. In this study, molecular signatures...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yayi, Song, Lele, Wang, Hao, Chen, Peixin, Liu, Yu, Sun, Hui, Li, Xiaobin, Dang, Shiying, Liu, Guifeng, Liu, Xinyi, Chen, Shifu, Zhang, Xiaoni, Hofman, Paul, Uchino, Junji, Park, Henry S., Pacheco, Jose M., Tabbò, Fabrizio, Xu, Mingyan, Dai, Jiawei, He, Kan, Yang, Yang, Zhou, Caicun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887584/ https://www.ncbi.nlm.nih.gov/pubmed/33643802 http://dx.doi.org/10.1002/advs.202003263

Ejemplares similares

Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC
por: He, Yayi, et al.
Publicado: (2021)

Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review
por: Li, Xiaobin, et al.
Publicado: (2020)

ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC
por: Chen, Yao, et al.
Publicado: (2020)

DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer
por: Dai, Jiawei, et al.
Publicado: (2021)

The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review
por: Liu, Yu, et al.
Publicado: (2021)

Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2020)

Combinational immunotherapy based on immune checkpoints inhibitors in small cell lung cancer: is this the beginning to reverse the refractory situation?
por: Guo, Haoyue, et al.
Publicado: (2020)

YAP1 expression is associated with survival and immunosuppression in small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2023)

Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population
por: Yao, Jianfei, et al.
Publicado: (2019)

cGAS-STING, an important pathway in cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2020)

Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer
por: Xu, Ruilian, et al.
Publicado: (2018)

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)
por: Guo, Haoyue, et al.
Publicado: (2021)

Distinct patterns of somatic genomic alterations and mutational signatures in central and peripheral-type small-cell lung cancer
por: Wang, Lei, et al.
Publicado: (2021)

Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedure
por: Chen, Peixin, et al.
Publicado: (2020)

Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
por: Sun, Xiao, et al.
Publicado: (2018)

Comparison of the next-generation sequencing (NGS) technology with culture methods in the diagnosis of bacterial and fungal infections
por: Chen, Peixin, et al.
Publicado: (2020)

Comparison of metagenomic next-generation sequencing technology, culture and GeneXpert MTB/RIF assay in the diagnosis of tuberculosis
por: Chen, Peixin, et al.
Publicado: (2020)

A rare multiple primary sarcomatoid carcinoma (SCA) of small intestine harboring driver gene mutations: a case report and a literature review
por: Zhu, Zhu, et al.
Publicado: (2021)

Uncovering the Binding Specificities of Lectins with Cells for Precision Colorectal Cancer Diagnosis Based on Multimodal Imaging
por: Tian, Rongrong, et al.
Publicado: (2018)

Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis
por: Peng, Honghua, et al.
Publicado: (2021)

Non‐small cell lung cancer in China
por: Chen, Peixin, et al.
Publicado: (2022)

Analysis of metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
por: Chen, Yu, et al.
Publicado: (2021)

Percutaneous Microwave Coagulation Therapy: A Promising Therapeutic Method for Breaking the Barrier of the Intertumor Heterogeneity
por: Guo, Haoyue, et al.
Publicado: (2021)

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC
por: He, Yayi, et al.
Publicado: (2018)

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer
por: He, Yayi, et al.
Publicado: (2016)

Third-Generation TKI Resistance Due to SCLC Transformation: A Case Report and Brief Review
por: Chen, Shen, et al.
Publicado: (2019)

Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2021)

Treatment of spine metastases in cancer: a review
por: Chen, Yu, et al.
Publicado: (2019)

Controllable Cell Deformation Using Acoustic Streaming for Membrane Permeability Modulation
por: Guo, Xinyi, et al.
Publicado: (2020)

Penetrable Nanoplatform for “Cold” Tumor Immune Microenvironment Reeducation
por: Chen, Qinjun, et al.
Publicado: (2020)

CD39: the potential target in small cell lung cancer
por: Chen, Shanhao, et al.
Publicado: (2020)

Efficient sequencing data compression and FPGA acceleration based on a two-step framework
por: Chen, Shifu, et al.
Publicado: (2023)

Intra-Tumor Heterogeneity of Colorectal Cancer Necessitates the Multi-Regional Sequencing for Comprehensive Mutational Profiling
por: Guo, Shaohua, et al.
Publicado: (2021)

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility
por: Liu, Mengyuan, et al.
Publicado: (2020)

GeneFuse: detection and visualization of target gene fusions from DNA sequencing data
por: Chen, Shifu, et al.
Publicado: (2018)

The Association between COX-2 Polymorphisms and Hematologic Toxicity in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy
por: Zhou, Fei, et al.
Publicado: (2013)

The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review
por: Song, Xinyu, et al.
Publicado: (2021)

Killer immunoglobulin-like receptors/human leukocyte antigen class-I, a crucial immune pathway in cancer
por: Xu, Yi, et al.
Publicado: (2020)

CD137, an attractive candidate for the immunotherapy of lung cancer
por: Ye, Lingyun, et al.
Publicado: (2020)

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m8n6ijocr703snh0qnen973vb4